BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26769407)

  • 1. A proposed staging system and stage-specific interventions for familial adenomatous polyposis.
    Lynch PM; Morris JS; Wen S; Advani SM; Ross W; Chang GJ; Rodriguez-Bigas M; Raju GS; Ricciardiello L; Iwama T; Rossi BM; Pellise M; Stoffel E; Wise PE; Bertario L; Saunders B; Burt R; Belluzzi A; Ahnen D; Matsubara N; Bülow S; Jespersen N; Clark SK; Erdman SH; Markowitz AJ; Bernstein I; De Haas N; Syngal S; Moeslein G
    Gastrointest Endosc; 2016 Jul; 84(1):115-125.e4. PubMed ID: 26769407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool.
    Lynch PM; Morris JS; Ross WA; Rodriguez-Bigas MA; Posadas J; Khalaf R; Weber DM; Sepeda VO; Levin B; Shureiqi I
    Gastrointest Endosc; 2013 Mar; 77(3):455-63. PubMed ID: 23332604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.
    Sample DC; Samadder NJ; Pappas LM; Boucher KM; Samowitz WS; Berry T; Westover M; Nathan D; Kanth P; Byrne KR; Burt RW; Neklason DW
    BMC Gastroenterol; 2018 Jul; 18(1):115. PubMed ID: 30012100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis.
    Thiruvengadam SS; Lopez R; O'Malley M; LaGuardia L; Church JM; Kalady M; Walsh RM; Burke CA
    Gastrointest Endosc; 2019 Feb; 89(2):345-354.e2. PubMed ID: 30081000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of colonic polyposis in young patients with familial adenomatous polyposis.
    Sarvepalli S; Burke CA; Monachese M; Leach BH; Laguardia L; O'Malley M; Kalady MF; Church JM
    Gastrointest Endosc; 2018 Oct; 88(4):726-733. PubMed ID: 29864420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
    Septer S; Lawson CE; Anant S; Attard T
    Fam Cancer; 2016 Jul; 15(3):477-85. PubMed ID: 27056662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nonampullary duodenal adenomas in patients with familial adenomatous polyposis versus patients with sporadic adenomas.
    Cassani LS; Lanke G; Chen HC; Wang X; Lynch P; Lee JH
    Gastrointest Endosc; 2017 Apr; 85(4):803-812. PubMed ID: 27530072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
    Hurley JJ; Thomas LE; Walton SJ; Thomas-Gibson S; Haycock A; Suzuki N; Mort M; Williams G; Morgan M; Clark SK; Sampson JR; Dolwani S
    Gastrointest Endosc; 2018 Oct; 88(4):665-673. PubMed ID: 29702101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic approaches for patients with coexisting familial adenomatous polyposis and colorectal cancer.
    Inoue Y; Ishida H; Ueno H; Kobayashi H; Yamaguchi T; Konishi T; Tomita N; Matsubara N; Ishida F; Hinoi T; Kanemitsu Y; Watanabe T; Sugihara K
    Jpn J Clin Oncol; 2016 Sep; 46(9):819-24. PubMed ID: 27418167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset of dysplasia in polyps in children with familial adenomatous polyposis: case report and literature review.
    Boskovic A; Djuricic S; Grujic B; Stankovic I
    Arab J Gastroenterol; 2014 Jun; 15(2):88-90. PubMed ID: 25097054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an aggressive depressed cancer in a case of familial adenomatous polyposis.
    Saito Y; Fujii T; Akasu T; Gotoda T; Kozu T; Saito D; Sano Y
    Endoscopy; 2002 May; 34(5):421-3. PubMed ID: 11972278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis.
    Detweiler CJ; Cardona DM; Hsu DS; McCall SJ
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26884076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting polyposis severity by proctoscopy: how reliable is it?
    Church J; Burke C; McGannon E; Pastean O; Clark B
    Dis Colon Rectum; 2001 Sep; 44(9):1249-54. PubMed ID: 11584194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis.
    Shibata C; Ogawa H; Miura K; Naitoh T; Yamauchi J; Unno M
    Tohoku J Exp Med; 2013 Feb; 229(2):143-6. PubMed ID: 23343691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of high-resolution endoscopy and narrow-band imaging in the evaluation of upper GI neoplasia in familial adenomatous polyposis.
    Lopez-Ceron M; van den Broek FJ; Mathus-Vliegen EM; Boparai KS; van Eeden S; Fockens P; Dekker E
    Gastrointest Endosc; 2013 Apr; 77(4):542-50. PubMed ID: 23352497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes.
    Kennedy RD; Potter DD; Moir CR; El-Youssef M
    J Pediatr Surg; 2014 Jan; 49(1):82-6. PubMed ID: 24439586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial adenomatous polyposis: complex patient management.
    Cyrany J; Bureš J; Rejchrt S; Kopáčová M
    Vnitr Lek; 2018; 64(6):635-641. PubMed ID: 30223661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey.
    Mraz KA; Hodan R; Rodgers-Fouche L; Arora S; Balaguer F; Guillem JG; Jeter JM; Kanth P; Li D; Liska D; Melson J; Perez K; Ricker C; Shirts BH; Vilar E; Katona BW; Dominguez-Valentin M
    Front Oncol; 2023; 13():1141810. PubMed ID: 37293588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Mesalazine in Familial Adenomatous Polyposis: Clinical Report of Reduction of Polyp Size in Patients with Ulcerative Colitis, and Safety Examination in Familial Adenomatous Polyposis Patients.
    Ishikawa H; Mutoh M; Abe T; Nakajima T; Takeuchi Y; Ezoe Y; Wakabayashi K; Doyama H; Sakai T
    Pharmacology; 2019; 104(1-2):51-56. PubMed ID: 31067545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.